295 related articles for article (PubMed ID: 15053774)
1. Antigenic cross-reactivity between different alleles of the Plasmodium falciparum merozoite surface protein 2.
Felger I; Steiger S; Hatz C; Smith T; Beck HP
Parasite Immunol; 2003; 25(11-12):531-43. PubMed ID: 15053774
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium falciparum: sequence diversity and antibody recognition of the Merozoite surface protein-2 (MSP-2) in Brazilian Amazonia.
Tonon AP; Hoffmann EH; Silveira LA; Ribeiro AG; Gonçalves CR; Ribolla PE; Wunderlich G; Ferreira MU
Exp Parasitol; 2004; 108(3-4):114-25. PubMed ID: 15582508
[TBL] [Abstract][Full Text] [Related]
4. Strain-specific humoral response to a polymorphic malaria vaccine.
Flück C; Smith T; Beck HP; Irion A; Betuela I; Alpers MP; Anders R; Saul A; Genton B; Felger I
Infect Immun; 2004 Nov; 72(11):6300-5. PubMed ID: 15501757
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.
Flueck C; Frank G; Smith T; Jafarshad A; Nebie I; Sirima SB; Olugbile S; Alonso P; Tanner M; Druilhe P; Felger I; Corradin G
Vaccine; 2009 May; 27(20):2653-61. PubMed ID: 19428875
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of a tryptophan-rich Plasmodium falciparum antigen associated with merozoites.
Ntumngia FB; Bouyou-Akotet MK; Uhlemann AC; Mordmüller B; Kremsner PG; Kun JF
Mol Biochem Parasitol; 2004 Oct; 137(2):349-53. PubMed ID: 15383306
[No Abstract] [Full Text] [Related]
7. Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1.
Cortés A; Mellombo M; Masciantonio R; Murphy VJ; Reeder JC; Anders RF
Infect Immun; 2005 Jan; 73(1):422-30. PubMed ID: 15618180
[TBL] [Abstract][Full Text] [Related]
8. Variant-specific antibodies to merozoite surface protein 2 and clinical expression of Plasmodium falciparum malaria in rural Amazonians.
Scopel KK; da Silva-Nunes M; Malafronte RS; Braga EM; Ferreira MU
Am J Trop Med Hyg; 2007 Jun; 76(6):1084-91. PubMed ID: 17556615
[TBL] [Abstract][Full Text] [Related]
9. Plasmodium falciparum: further characterization of a functionally active region of the merozoite invasion ligand EBA-175.
Sim BK; Carter JM; Deal CD; Holland C; Haynes JD; Gross M
Exp Parasitol; 1994 May; 78(3):259-68. PubMed ID: 7512929
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium falciparum: extensive polymorphism in merozoite surface antigen 2 alleles in an area with endemic malaria in Papua New Guinea.
Felger I; Tavul L; Kabintik S; Marshall V; Genton B; Alpers M; Beck HP
Exp Parasitol; 1994 Sep; 79(2):106-16. PubMed ID: 7914494
[TBL] [Abstract][Full Text] [Related]
11. Relationship between in vivo synchronicity of Plasmodium falciparum and allelic diversity.
Touré-Ndouo FS; Zang-Edou ES; Bisvigou U; Mezui-Me-Ndong J
Parasitol Int; 2009 Dec; 58(4):390-3. PubMed ID: 19660576
[TBL] [Abstract][Full Text] [Related]
12. Allelic family-specific humoral responses to merozoite surface protein 2 (MSP2) in Gabonese residents with Plasmodium falciparum infections.
Ekala MT; Jouin H; Lekoulou F; Mercereau-Puijalon O; Ntoumi F
Clin Exp Immunol; 2002 Aug; 129(2):326-31. PubMed ID: 12165090
[TBL] [Abstract][Full Text] [Related]
13. Allelic polymorphisms in apical membrane antigen-1 are responsible for evasion of antibody-mediated inhibition in Plasmodium falciparum.
Healer J; Murphy V; Hodder AN; Masciantonio R; Gemmill AW; Anders RF; Cowman AF; Batchelor A
Mol Microbiol; 2004 Apr; 52(1):159-68. PubMed ID: 15049818
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to rifin: a component of naturally acquired responses to Plasmodium falciparum variant surface antigens on infected erythrocytes.
Abdel-Latif MS; Cabrera G; Köhler C; Kremsner PG; Luty AJ;
Am J Trop Med Hyg; 2004 Aug; 71(2):179-86. PubMed ID: 15306707
[TBL] [Abstract][Full Text] [Related]
15. Differential antibody recognition of four allelic variants of the merozoite surface protein-2 (MSP-2) of Plasmodium falciparum.
Tonhosolo R; Wunderlich G; Ferreira MU
J Eukaryot Microbiol; 2001; 48(5):556-64. PubMed ID: 11596920
[TBL] [Abstract][Full Text] [Related]
16. Effect of the malaria vaccine Combination B on merozoite surface antigen 2 diversity.
Flück C; Schöpflin S; Smith T; Genton B; Alpers MP; Beck HP; Felger I
Infect Genet Evol; 2007 Jan; 7(1):44-51. PubMed ID: 16647307
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and antigenic properties of Pf332-C231, a fragment of a non-repeat region of the Plasmodium falciparum antigen Pf332.
Balogun HA; Vasconcelos NM; Lindberg R; Haeggström M; Moll K; Chen Q; Wahlgren M; Berzins K
Vaccine; 2009 Dec; 28(1):90-7. PubMed ID: 19822232
[TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology of malaria in Cameroon. XVIII. Polymorphisms of the Plasmodium falciparum merozoite surface antigen-2 gene in isolates from symptomatic patients.
Basco LK; Tahar R; Escalante A
Am J Trop Med Hyg; 2004 Mar; 70(3):238-44. PubMed ID: 15031510
[TBL] [Abstract][Full Text] [Related]
19. Antibody recognition of heterologous variant surface antigens after a single Plasmodium falciparum infection in previously naive adults.
Elliott SR; Payne PD; Duffy MF; Byrne TJ; Tham WH; Rogerson SJ; Brown GV; Eisen DP
Am J Trop Med Hyg; 2007 May; 76(5):860-4. PubMed ID: 17488905
[TBL] [Abstract][Full Text] [Related]
20. Diversity of Plasmodium falciparum vaccine candidate merozoite surface protein 4 (MSP4) in a natural population.
Benet A; Tavul L; Reeder JC; Cortés A
Mol Biochem Parasitol; 2004 Apr; 134(2):275-80. PubMed ID: 15003847
[No Abstract] [Full Text] [Related]
[Next] [New Search]
